Titan Pharmaceuticals Inc (TTNP) — Cash Flow Reinvestment Rate
Titan Pharmaceuticals Inc (TTNP) has a Cash Flow Reinvestment Rate of 0.00x as of June 2016, reinvesting $9.00K (capex $9.00K ) from operating cash flow of $13.51 Million. See TTNP free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Titan Pharmaceuticals Inc Cash Flow Reinvestment Rate (1997–2016)
Historical reinvestment intensity for Titan Pharmaceuticals Inc across 3 annual periods. For the full cash flow conversion analysis, see Titan Pharmaceuticals Inc cash flow conversion.
Annual Cash Flow Reinvestment Rate for Titan Pharmaceuticals Inc (1997–2016)
Year-by-year capital reinvestment analysis for Titan Pharmaceuticals Inc. See TTNP financial flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2016 | 0.05x | $342.00K | $6.29 Million | $171.00K | ▼ -91.4% |
| 2012 | 0.63x | $1.15 Million | $1.83 Million | $1.15 Million | ▲ +4377.3% |
| 1997 | 0.01x | $100.00K | $7.10 Million | $100.00K | — |